cetylpyridinium chloride anhydrous has been researched along with vasoactive intestinal peptide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branch, DR; Colombatti, A; Dopsaj, M; Dopsaj, V; Glisic, S; Sakarellos-Daitsiotis, MM; Veljkovic, M; Veljkovic, N; Veljkovic, V | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and vasoactive intestinal peptide
| Article | Year |
|---|---|
Physical activity and natural anti-VIP antibodies: potential role in breast and prostate cancer therapy.
Topics: Adult; Aged; Antibodies; Athletes; Breast Neoplasms; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Health; Humans; Male; Middle Aged; Motor Activity; Peptides; Prostatic Neoplasms; Vasoactive Intestinal Peptide | 2011 |